We found the G-CSF treatment can upregulate level of G-CSFR (Fig. 1a) and G-CSF protein (Fig. 1b) in the frontal and middle region of stroke treated group with G-CSF treatment compared to vehicle treated group in BCAO. The gene discussed is CSF3R; the disease is Stroke.